ArticleJournal of medical case reports2026
Fetal Kabuki syndrome caused by a novel gene variation in KMT2D with primary carnitine deficiency: a case report.
Article in Journal of medical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundKabuki syndrome (KS) is an autosomal dominant syndrome involving multiple organs and systems and can be caused by mutation in KMT2D and KDM6A genes. CASE REPORT: Here, we report the case of a pregnant woman who underwent prenatal family full-exon sequencing due to fetal multi-system abnormalities on ultrasound. Analysis revealed that the fetus had two rare congenital diseases: KS type 1 caused by mutation in the KMT2D and primary carnitine deficiency caused by mutation in the SLC22A5 gene, thus enriching our understanding of the prenatal ultrasound phenotype and gene mutation spectrum of KS. This case of fetal KS was caused by a novel frameshift mutation at the KMT2D gene locus c.14132_14133del which is not included in the ClinVar or Human Gene Mutation Database (HGMD) professional databases.
conclusionPrenatal ultrasound findings of KS are not unique, and the pathogenic genes associated with KS cannot be detected by conventional karyotype/microarray analyses. Consequently, the prenatal diagnosis of KS remains very difficult. However, whole-exome sequencing is recommended when multiple system abnormalities are present, routine testing is negative, and there is a high suspicion of a monogenic disorder. This strategy will identify fetal gene deletion or mutation early, allow informed genetic counselling, and help reduce the incidence of adverse pregnancy outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.